Idenix Pharmaceuticals Trust Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate the Acquis...
09 Junio 2014 - 12:12PM
Business Wire
Former United States Securities and Exchange Commission attorney
Willie Briscoe and the securities litigation firm of Powers Taylor
LLP are investigating potential claims against the Board of
Directors of Idenix Pharmaceuticals Inc. (“Idenix”) (NasdaqGS:
IDIX) concerning the acquisition by Merck & Co Inc. Under the
terms of the agreement, valued at approximately $3.85 billion,
Idenix shareholders will only receive $24.50 in cash per Idenix
share owned.
If you are an affected investor, and you want to learn more
about the investigation or if you have information that you believe
would be helpful to the determination of the fairness of the
proposed transaction, contact Willie Briscoe at The Briscoe Law
Firm, PLLC, (214) 239-4568, or via email at
WBriscoe@TheBriscoeLawFirm.com, or Patrick Powers at Powers Taylor
LLP, toll free (877) 728-9607, via e-mail at
shareholder@powerstaylor.com. There is no cost or fee to you.
The investigation centers on whether Idenix’s Board of Directors
is acting in the shareholders’ best interests, whether the board is
properly negotiating a higher share price for the shareholders, and
whether the board has employed an adequate process to review and
act on the proposed transaction.
The Briscoe Law Firm, PLLC is a full service business litigation
and shareholder rights advocacy firm with more than 20 years of
experience in complex litigation and transactional matters.
Powers Taylor LLP is a boutique litigation law firm that handles
a variety of complex business litigation matters, including claims
of investor and stockholder fraud, shareholder oppression,
shareholder derivative suits, and security class actions.
The Briscoe Law Firm, PLLCWillie Briscoe,
214-239-4568WBriscoe@TheBriscoeLawFirm.comorPowers Taylor
LLPPatrick Powers, 877-728-9607shareholder@powerstaylor.com
(MM) (NASDAQ:IDIX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
(MM) (NASDAQ:IDIX)
Gráfica de Acción Histórica
De May 2023 a May 2024